Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course--a case report. 2010

Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
Department of Gynecological Cytology, University Department of Gynecology and Obstetrics, University Hospital Center Rijeka, Rijeka, Croatia. roberta.rubesa@gmail.com

Villoglandular papillary adenocarcinoma (VGA) of cervix is an uncommon but well recognized histologic subtype of cervical adenocarcinoma which usually affects young women. Based on the favorable outcomes reported in most previous cases the tumor is generally considered to have an indolent clinical course with excellent prognosis. We present a case of a 22-year-old woman admitted at our Department for glandular abnormality on cervical smear and episodes of vaginal discharge. In the Pap smear, the cytological features were suspicious but not diagnostic of adenocarcinoma, therefore reported as atypical glandular cells (AGC). Histological examination confirmed VGA associated with lymphovascular space invasion. The patient underwent radical operative procedure. Intraoperative cytologic examination detected pelvic lymph nodes metastasis. The patient was confirmed to be in an advanced stage - III B (FIGO). During a two years follow-up period a rapid dissemination of the tumor occurred and resulted with a fatal outcome. Although VGA has been reported to have a favorable prognosis, several cases with lymph node involvement have already been described. Cervical smears examination would be helpful for an early diagnosis of VGA, however the cytologic recognition is often difficult. Further investigation of the pathogenesis, diagnosis and therapy of the tumor is needed.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000231 Adenocarcinoma, Papillary An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed) Adenocarcinomas, Papillary,Papillary Adenocarcinoma,Papillary Adenocarcinomas
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
January 1998, Tumori,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
July 1998, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
September 1999, European journal of obstetrics, gynecology, and reproductive biology,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
August 2000, Journal of surgical oncology,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
January 2009, European journal of gynaecological oncology,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
December 2023, Journal of menopausal medicine,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
September 2002, Journal of experimental & clinical cancer research : CR,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
January 1997, The West Virginia medical journal,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
January 2009, Acta obstetricia et gynecologica Scandinavica,
Roberta Rubesa-Mihaljević, and Danijela Vrdoljak-Mozetic, and Damjana Versa Ostojić, and Snjezana Stemberger-Papić, and Nebojsa Sindik, and Maja Krasević
January 2004, Gynecologic oncology,
Copied contents to your clipboard!